Trastuzumab-Conjugated Nanoparticles: Design And Synthesis Of Trastuzumab-Conjugated Nanoparticles For Targeted Delivery Of Chemotherapeutic Agents To Her2-Positive Breast Cancer Cells. VER [Internet]. 2025 Nov. 24 [cited 2026 Jun. 10];8(12s):310-5. Available from: https://verjournal.com/index.php/ver/article/view/957